
Sign up to save your podcasts
Or


The controversial drug is back in the news. In the early days of the pandemic, President Trump and some doctors touted it as an effective treatment. But studies soon discredited the treatment. Now, in an unexpected twist, some research papers dismissing the drug have also been thrown in doubt. So how useful is Hydroxychloroquine and how reliable are the reviews we rely on to assess a drug's safety? Laura Carlson speaks to Bloomberg reporters Michelle Cortez and Robert Langreth for answers.
See omnystudio.com/listener for privacy information.
 By Bloomberg
By Bloomberg3.7
805805 ratings
The controversial drug is back in the news. In the early days of the pandemic, President Trump and some doctors touted it as an effective treatment. But studies soon discredited the treatment. Now, in an unexpected twist, some research papers dismissing the drug have also been thrown in doubt. So how useful is Hydroxychloroquine and how reliable are the reviews we rely on to assess a drug's safety? Laura Carlson speaks to Bloomberg reporters Michelle Cortez and Robert Langreth for answers.
See omnystudio.com/listener for privacy information.

91,072 Listeners

21,996 Listeners

78,347 Listeners

43,570 Listeners

14,344 Listeners

407 Listeners

2,169 Listeners

421 Listeners

1,383 Listeners

965 Listeners

112,549 Listeners

56,391 Listeners

193 Listeners

15,546 Listeners

3,302 Listeners

16,245 Listeners

6,212 Listeners

68 Listeners

31 Listeners

4 Listeners

155 Listeners

58 Listeners

232 Listeners

229 Listeners

9,121 Listeners

60 Listeners

63 Listeners

83 Listeners

382 Listeners

22 Listeners

12 Listeners

986 Listeners

7 Listeners

2 Listeners

78 Listeners